PubMed:24671324 / 133-307
Annnotations
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 9826 | 0-10 | ChemicalEntity | denotes | Bortezomib | MESH:D000069286 |
| 9827 | 25-38 | ChemicalEntity | denotes | dexamethasone | MESH:D003907 |
| 9828 | 116-136 | DiseaseOrPhenotypicFeature | denotes | bacterial infections | MESH:D001424 |
| 9829 | 140-148 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 9830 | 161-173 | DiseaseOrPhenotypicFeature | denotes | malignancies | MESH:D009369 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 0-174 | Sentence | denotes | Bortezomib and high-dose dexamethasone-containing regimens are considered to be generally tolerable with few severe bacterial infections in patients with B-cell malignancies. |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | high |
| T2 | 90-99 | GeneOrGeneProduct | denotes | tolerable |
| T3 | 156-160 | GeneOrGeneProduct | denotes | cell |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | high |
| T2 | 156-160 | GeneOrGeneProduct | denotes | cell |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T3 | 116-136 | DiseaseOrPhenotypicFeature | denotes | bacterial infections | D001424 |
| T4 | 161-173 | DiseaseOrPhenotypicFeature | denotes | malignancies | D009369 |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T3 | 116-139 | DiseaseOrPhenotypicFeature | denotes | bacterial infections in | 0005113 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T3 | 116-136 | DiseaseOrPhenotypicFeature | denotes | bacterial infections | D001424 |
| T4 | 161-173 | DiseaseOrPhenotypicFeature | denotes | malignancies | D009369 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T3 | 116-136 | DiseaseOrPhenotypicFeature | denotes | bacterial infections | D001424 |
| T4 | 161-173 | DiseaseOrPhenotypicFeature | denotes | malignancies | D009369 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T5 | 0-10 | ChemicalEntity | denotes | Bortezomib | D000069286|http://purl.obolibrary.org/obo/CHEBI_52717 |
| T7 | 25-38 | ChemicalEntity | denotes | dexamethasone | D003907|http://purl.obolibrary.org/obo/CHEBI_41879 |
LitCoin-NCBITaxon-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 140-148 | OrganismTaxon | denotes | patients |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T7 | 25-38 | ChemicalEntity | denotes | dexamethasone | http://purl.obolibrary.org/obo/CHEBI_41879|D003907 | |
| T5 | 0-10 | ChemicalEntity | denotes | Bortezomib | http://purl.obolibrary.org/obo/CHEBI_52717|D000069286 | |
| T4 | 161-173 | DiseaseOrPhenotypicFeature | denotes | malignancies | D009369 | |
| T99350 | 116-136 | DiseaseOrPhenotypicFeature | denotes | bacterial infections | D001424 | |
| T2012 | 140-148 | OrganismTaxon | denotes | patients |